Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing

Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Med Rep
Huvudupphovsmän: GIZZO, SALVATORE, ANDRISANI, ALESSANDRA, NOVENTA, MARCO, MANFÈ, SERENA, OLIVA, ALESSANDRA, GANGEMI, MICHELE, NARDELLI, GIOVANNI BATTISTA, AMBROSINI, GUIDO
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2015
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526099/
https://ncbi.nlm.nih.gov/pubmed/26059981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3904
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk